Physician

Infectious Disease

Dr. Steven A. Yukl, MD

Steven A. Yukl is an expert in the field of Infectious Disease. Steven Yukl is a published doctor and has 18 publications published. The lastest was: 'Site-Specific Differences in T Cell Frequencies and Phenotypes in the Blood and Gut of HIV-Uninfected and ART-Treated HIV+ Adults.'

Publications

Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells.
Decreased HIV-1 Transcription in CCR5 Delta-32 Heterozygotes On Suppressive Antiretroviral Therapy.
A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+T cells, including myeloid cells.
Discordance between peripheral and colonic markers of inflammation during suppressive ART.
Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers.
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.
The Distribution of HIV DNA and RNA in Cell Subsets Differs in Gut and Blood of HIV-Positive Patients on ART: Implications for Viral Persistence.
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient.
Site-Specific Differences in T Cell Frequencies and Phenotypes in the Blood and Gut of HIV-Uninfected and ART-Treated HIV+ Adults.
Advantages of using the QIAshredder instead of restriction digestion to prepare DNA for droplet digital PCR.
Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.
Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.
Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity.
Blood and guts and HIV: preferential HIV persistence in GI mucosa.
The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit.

Schools

University of Mi Med Sch

Doctors Specialties

Infectious Disease Medicine
Infectious Disease

Accepted Insurances

Education

UCSF
Duke University Hospital

Hospital

San Francisco VA Medical Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Joseph M. McCune III, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jesus Roland M. Gatpolintan, MD This Doctor is OpenDoctor Recommended.
	Dr. Jose Eguia, MD This Doctor is OpenDoctor Recommended.
	Dr. Sanjiv M. Baxi, MD
	Dr. Harry W. Lampiris, MD This Doctor is OpenDoctor Recommended.
	Dr. Milton H. Louie, MD This Doctor is OpenDoctor Recommended.
	Dr. Snigdha Vallabhaneni, MD This Doctor is OpenDoctor Recommended.
	Dr. Erin A. Hsu, MD This Doctor is OpenDoctor Recommended.
	Dr. David R. Bangsberg, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lynn E. Connolly, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan S. Philip, MD This Doctor is OpenDoctor Recommended.
	Dr. Makeda L. Robinson, MD